Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic Patients

NCT02894151 is registered in ClinicalTrials.gov with Chulalongkorn University as lead sponsor.

NCT NCT02894151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02894151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic Patients
Lead sponsor
Chulalongkorn University
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2015
Completion date
May 31, 2016
Enrollment
50 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

clinically diagnosed endometriotic patient was defined as a woman who has pelvic pain and at least one evidence of pv or tvs